SwitzerReport

Independent. Trusted. Proven.

Reports

Browse current and previous editions of Switzer Report

Thursday Edition, 9 March 2023
Tony Featherstone

Two sporting companies to watch

Tony Featherstone · March 9, 2023

Some experts I know believe our sporting industry is entering a golden decade. Here are two ways to play the sporting theme. In his article today, Tony explores two ways to play the sports theme:

Featured posts Premium
Maureen Jordan

“HOT” stock: Xero (XRO)

Maureen Jordan · March 9, 2023

In our “HOT” stock column, Michael Gable, Managing Director of Fairmont Equities, says it’s wise to keep an eye on accounting-based software platform Xero (XRO).

Shares Premium
Paul Rickard

Questions of the Week

Paul Rickard · March 9, 2023

How will the proposed super tax impact a two member SMSF? I have done well out of Mineral Resources – should I take profits and switch into BHP? What is the significance of an inverted yield curve? If James Hardie drops out of the top 20 index, will this impact its share price

Question of the Week Premium
Monday Edition, 6 March 2023
Peter Switzer

Joye’s markets Armageddon gives me no joy!

Peter Switzer · March 6, 2023

Experts such as Chris Joye say that his team predicts a serious US and global recession by late 2023 or early 2024. As Billy Joel might say, they could be right, they could be wrong or they could be crazy! Here’s my view…

Featured posts Premium
Maureen Jordan

HOT stock: Endeavour (EDV)

Maureen Jordan · March 6, 2023

In our “HOT” stock column today, Raymond Chan, Head of Asian Desk at Morgans, says why he thinks Endeavour (EDV) should be added to your portfolio.

Shares Premium
James Dunn

My 3 Meditech picks

James Dunn · March 6, 2023

In my article today I want to look at the devices part of the biotech world: here are 3 examples of some of the wonderful technology coming out of Australia and being taken to a global market.

Shares Premium
Rudi Filapek-Vandyck

Buy, Hold, Sell — What the Brokers Say

Rudi Filapek-Vandyck · March 6, 2023

For the week ending Friday March 3 there were 15 upgrades and 10 downgrades for ASX-listed companies as brokers in the FNArena database reviewed results from the final week of the February reporting season.

Buy, Sell, Hold Premium
Switzer on Saturday, 4 March 2023
Thursday Edition, 2 March 2023
Maureen Jordan

“HOT” stock: ResMed (RMD)

Maureen Jordan · March 2, 2023

In our “HOT” stock column, Michael Gable, Managing Director of Fairmont Equities, says that ResMed (RMD) RMD has come back to the long-term uptrend line and is starting to show some positive momentum once again.

Shares Premium
Paul Rickard

Questions of the Week

Paul Rickard · March 2, 2023

What is a good re-entry price for Fortescue? What other changes to super are on the Government’s agenda? Should I take part in Star’s entitlement issue? Can I still access Woodside’s whopper dividend?

Question of the Week Premium

You don't have credit card details available. You will be redirected to update payment method page. Click OK to continue.